Hongxia Shi Selected Research

Hongxia Shi Research Topics

2	Neoplasms (Cancer) 11/2023 - 11/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 05/2021
2	Residual Neoplasm 05/2021 - 01/2021
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 01/2016
1	Philadelphia Chromosome 03/2024
1	Gout 01/2024
1	Brain Injuries (Brain Injury) 01/2024
1	Cerebral Hemorrhage 01/2024
1	Fanconi Syndrome (Syndrome, Fanconi) 12/2023
1	Fatigue 11/2023
1	Dizziness (Lightheadedness) 11/2023
1	Leukemia 04/2023
1	Essential Thrombocythemia 11/2021
1	Polycythemia Vera 11/2021
1	Primary Myelofibrosis (Myelosclerosis) 11/2021
1	Splenomegaly 01/2020
1	Nephritis 10/2019
1	Segmental glomerulosclerosis 10/2019
1	Hematuria 10/2019
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2019
1	Lung Injury 01/2019
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2019
1	Neuroblastoma 01/2018
1	Blast Crisis (Blast Phase) 01/2016
1	Inflammation (Inflammations) 12/2014
1	Melanoma (Melanoma, Malignant) 01/2014
1	Multiple Myeloma 01/2014
1	Testicular Neoplasms (Testicular Cancer) 01/2014
1	Bruton type agammaglobulinemia 10/2002

2	Core Binding Factors (Core-Binding Factor)IBA 10/2023 - 05/2021
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2016
2	Particulate MatterIBA 01/2019 - 12/2014
1	Xanthine OxidaseIBA 01/2024
1	Febuxostat FDA Link 01/2024
1	Immunoglobulins (Immunoglobulin)IBA 12/2023
1	luspaterceptIBA 11/2023
1	BilirubinIBA 11/2023
1	AclarubicinIBA 10/2023
1	HomoharringtonineIBA 10/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2023
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 10/2023
1	Immunoglobulin A (IgA)IBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	EndotoxinsIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2018
1	Alitretinoin FDA Link 01/2018
1	Isotretinoin (Accutane)FDA LinkGeneric 01/2018
1	Dasatinib (BMS 354825)FDA Link 01/2016
1	nilotinib FDA Link 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Bortezomib (Velcade)FDA Link 01/2014
1	AntigensIBA 01/2014

5	Therapeutics 03/2024 - 01/2014
1	Stem Cell Transplantation 03/2024
1	Induction Chemotherapy 10/2023
1	Transplantation 04/2023
1	Consolidation Chemotherapy 01/2021
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2002